63 results
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
2 Aug 23
Other Events
2:51pm
leadership and R&D team (Boston, USA and Saskatoon, Canada) Experienced Board of Directors An Agricultural Bioscience Company Focused on the Oilseed … in aquafeed & human trials “Camelina DHA 1 oil effectively replaces fish oil Yield10 secures commercial rights Funds RRES R&D program Assists
FWP
YTEN
Yield10 Bioscience Inc
25 Oct 19
Free writing prospectus
12:49pm
and R&D team (Boston, USA and Saskatoon, Canada) TRAIT FACTORY Performance traits for major crops and specialty products Relationships in place … 4
Near-term Milestones Corporate and R&D Milestones Period Completed Initiate early development program in corn to evaluate novel traits Jan 2019
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
11 Sep 23
Other Events
9:11am
in aquafeed & human trials “Camelina DHA 1 oil effectively replaces fish oil Yield10 secures commercial rights Funds RRES R&D program Assists with patent … Revenue __ $ 0.1 million $ 0.1 million $ 0.25 million R&D Expense $ 2.0 million $ 2.0 million $ 4.2 million $ 3.8 million G&A Expense $ 1.7 million
8-K
YTEN
Yield10 Bioscience Inc
17 Jul 13
Metabolix Announces Promotion of Johan Van Walsem
12:00am
month period as Senior Vice President, R&D and Bioprocessing at Joule Biotechnologies, a clean technology start-up company. Previously, Mr. van Walsem
8-K
EX-99.1
8q5v twg7uklb2
11 Aug 21
Yield10 Bioscience Announces Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
6ltpoe o4dygkessa
24 Sep 18
Other Events
4:15pm
8-K
EX-99.1
34pzd5 lhm6p60
11 Aug 20
Yield10 Bioscience Signs Research Agreement with GDM
8:42am
8-K
EX-10.1
gg6trp0r
4 Aug 14
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in Equity Financing
12:00am
S-1/A
EX-10.16
2v38eb0369hm6j3z iz
31 Aug 06
IPO registration (amended)
12:00am
424B4
ph7mg1yo4hqq
19 Oct 20
Prospectus supplement with pricing info
4:51pm